Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients

/PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized...

Related Keywords

London ,City Of ,United Kingdom ,Chengdu ,Sichuan ,China ,Dong Xie ,Zhejiang ,Chinese , ,Department Of Infection ,Drug Administration ,National List Of Essential Medical Insurance ,Chengdu Public Health Clinical Medical Center ,Chinese Medical Association Infectious Diseases Unit ,Clinical Society ,China Center ,Chief Scientific Officer ,Frontier Biotechnologies ,Frontier Biotechnologie ,State Drug Administration ,Chinese Medical Association ,Infectious Diseases Unit ,Disease Control ,National List ,Essential Medical Insurance ,Industrial Injury Insurance ,Maternity Insurance Drugs ,